文献速递垂体与肾上腺疾病

基线血浆醛固酮水平与肾素活性可助原发性醛固酮增多症免做确证试验

Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

本研究基于日本PA登记库(JPAS/JRAS)的多机构回顾性队列,分析2256例接受卡托普利试验(CCT)和/或1184例接受盐水输注试验(SIT)的PA患者。在肾素抑制(bPRA≤0.3)患者中,预测SIT阳性所需bPAC cut-off为30.85 ng/dL,低于预测CCT阳性的56.35 ng/dL;bPRA≤0.6时bPAC≥30.85对SIT和CCT阳性的特异度分别为100.0%和97.0%。结论认为bPAC≥30.85且bPRA≤0.6时可省略确证试验。

要点

  • 在bPRA≤0.3的PA患者中,预测SIT阳性所需bPAC cut-off为30.85 ng/dL,低于预测CCT阳性的56.35 ng/dL。
  • bPRA≤0.6时,bPAC≥30.85预测SIT和CCT阳性的特异度分别为100.0%和97.0%。
  • 纳入bPRA>0.6患者后,bPAC≥30.85预测SIT和CCT阳性的特异度下降。

核心结论

  • 在bPRA≤0.6且bPAC≥30.85 ng/dL的患者中,可省略原发性醛固酮增多症的确证试验。

研究设计与样本

  • 多机构回顾性队列研究,使用日本PA登记库(JPAS/JRAS)。
  • 纳入接受CCT(n=2256)和/或SIT(n=1184)的PA患者。

主要发现

  • 在肾素抑制(bPRA≤0.3)患者中,预测SIT阳性所需bPAC cut-off为30.85 ng/dL,低于预测CCT阳性的56.35 ng/dL。
  • bPRA≤0.6时,bPAC≥30.85预测SIT阳性的特异度为100.0%,预测CCT阳性的特异度为97.0%。
  • 纳入bPRA>0.6患者后,bPAC≥30.85预测SIT和CCT阳性的特异度下降。

关键数值与推荐

  • bPAC≥30.85 ng/dL且bPRA≤0.6时,可省略确证试验。
  • bPRA≤0.3时,预测SIT阳性bPAC cut-off为30.85 ng/dL,预测CCT阳性bPAC cut-off为56.35 ng/dL。

临床怎么用

  • 对bPRA≤0.6且bPAC≥30.85 ng/dL的PA患者,可省略确证试验。

局限性

  • 既往研究因患者数量少和单中心设计存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Previous studies have proposed cutoff value of baseline plasma aldosterone concentration (bPAC) under renin suppression that could diagnose primary aldosteronism (PA) without confirmatory testing. However, those studies are limited by selection bias due to a small number of patients and a single-center study design. OBJECTIVE: This study aimed to determine cutoff value of bPAC and baseline plasma renin activity (bPRA) for predicting positive results in confirmatory tests for PA. DESIGN: The multi-institutional, retrospective, cohort study was conducted using the PA registry in Japan (JPAS/JRAS). We compared bPAC in patients with PA who showed positive and negative captopril challenge test (CCT) or saline infusion test (SIT) results. PATIENTS: Patients with PA who underwent CCT (n = 2256) and/or SIT (n = 1184) were studied. MAIN OUTCOME MEASURES: The main outcomes were cutoff value of bPAC (ng/dL) and bPRA (ng/mL/h) for predicting positive CCT and/or SIT results. RESULTS: In patients with renin suppression (bPRA ≤ 0.3), the cutoff value of bPAC that would give 100% specificity for predicting a positive SIT result was lower than that for predicting a positive CCT result (30.85 vs 56.35, respectively). Specificities of bPAC cutoff values ≥ 30.85 for predicting positive SIT and CCT results remained high (100.0% and 97.0%, respectively) in patients with bPRA ≤ 0.6. However, the specificities of bPAC cutoff values ≥ 30.85 for predicting positive SIT and CCT results decreased when patients with bPRA > 0.6 were included. CONCLUSION: Confirmatory testing could be omitted in patients with bPAC ≥ 30.85 in the presence of bPRA ≤ 0.6.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kawashima J, Araki E, Naruse M, et al. Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism. J Clin Endocrinol Metab. 2020. PMID: 32157288. doi:10.1210/clinem/dgaa117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。